about
The laminin response in inflammatory bowel disease: protection or malignancy?A metagenomic insight into our gut's microbiomeA fibrolytic potential in the human ileum mucosal microbiota revealed by functional metagenomicFaecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsThe Enterococcus faecalis virulence factor ElrA interacts with the human Four-and-a-Half LIM Domains Protein 2Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract.Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats.The impact of ATRA on shaping human myeloid cell responses to epithelial cell-derived stimuli and on T-lymphocyte polarizationThe influence of diet on the gut microbiota and its consequences for health.Lactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice.The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner.Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells.TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways.Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose.Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells.Karyotypic and phenotypic variations between cell lines established from a primary colorectal tumour and two corresponding metastases from one patient.Rise in cytosolic Ca2+ concentration induced by P2-purinoceptor activation in isolated myocytes from the rat gastrointestinal tract.In vitro contractile effects of short chain fatty acids in the rat terminal ileum.Functional mapping of NPY/PYY receptors in rat and human gastro-intestinal tract.[Dietary fibers and colorectal cancer. Experimental studies, epidemiology, mechanisms].Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines.Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide.SCFAs strongly stimulate PYY production in human enteroendocrine cells.Treatment of rat proximal and distal colonic cells with sodium orthovanadate enhances their adhesion and survival in primary culture.Development of a monoclonal antibody against dentin phosphophoryn: a tool to study odontoblastic activity.[Expression of the gene of cholecystokinin. Demonstration from duodenal biopsies in man]Identification of secreted CD155 isoforms.Butyrate enhances major histocompatibility complex class I, HLA-DR and ICAM-1 antigen expression on differentiated human intestinal epithelial cells.[Impact of newly developed metagenomic tools on our knowledge of the gut microbiota and its role in human health: diagnostic and therapeutic issues].Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity.[Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer]Humans as holobionts: implications for prevention and therapy.Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells.Impact of high-fat feeding on basic helix-loop-helix transcription factors controlling enteroendocrine cell differentiationButyrate Produced by Commensal Bacteria Down-Regulates () Expression a Dual Mechanism in Human Intestinal Epithelial CellsIdentification of the novel role of butyrate as AhR ligand in human intestinal epithelial cellsPrediction of the intestinal resistome by a three-dimensional structure-based methodA Guide for Ex Vivo Handling and Storage of Stool Samples Intended for Fecal Microbiota Transplantation.Identification and characterization of a rat protein (p 105) auto-antigenic in rats bearing a progressive syngeneic colon carcinomaAnalysis of the state of differentiation of two rat colon carcinoma clones with distinct tumorigenic properties
P50
Q27333814-8867B6B0-4541-47BE-B551-8E7E2EF0371DQ28265135-CC596516-CE6B-473A-898A-A1B73EF60544Q28817237-AA7F96BF-0AD9-4106-AE16-423A5E1BBE5AQ29614261-01D53F17-1A5A-487C-A891-0031998F0AB3Q33870920-C49CB7B1-9621-4AD8-A1E8-14E12FAFF3E0Q34387493-AE7F4178-9FA7-4262-9F41-C1C2104777DBQ35353560-BB575508-4D1F-4D29-878F-E0F41F61DE16Q35508697-16104D26-CE1C-4931-A03B-5CE448F185A9Q35548074-6DA0C801-F90D-4298-9B0B-8D215FCF0B7CQ35800407-173EBA9A-E6DD-425D-87B4-AA07A2FD6675Q38701196-66401C42-13B6-4F91-92EB-85D49CFA3CB5Q38713387-7E6FE234-FF43-4389-93F8-B7B043D281CEQ38758563-59F7F2A2-76B1-44EC-84D0-6020042C7B9AQ40526089-E6687D08-2529-4061-ABCD-35F712076D04Q41575703-7561262F-F16E-4AFB-8BCA-D64D4FE04F7BQ41586816-B5600DB5-668F-49CD-81F8-96E367B5B977Q41920169-9F198721-278B-4524-AD64-A9DAAFA7EAC5Q43226016-5DD2E843-D158-4442-BBC9-9A029D5D6A1DQ44182435-9B1965D8-35FC-4FAA-8CDD-C7C8E347B4D9Q44212429-A9E3EF4E-020A-43C8-9B37-4211CC5E5C02Q44623973-244832F7-66DC-43EA-899A-9173EEBF3221Q46582653-B1301119-C4F7-46D4-AB58-26C2A9D6FBE7Q48293164-BE70B898-3A9C-42EA-8E1A-314940D2C696Q50528867-8E1AFC66-4C37-4146-8B2E-7CBD557935ABQ50773970-3D5DA8AB-FD50-4204-902A-A64389B1A9F9Q51586592-35B2BB95-C14A-4D04-8981-D211ABF29B82Q51831235-49A078E4-36EA-4DBF-A234-563207D4F86AQ52200035-4F763F2F-6F8D-47CB-9811-A9B9EFE0E919Q53614534-88F4F88E-3685-44DC-B9B5-F6B641C0B6E6Q54259817-7C41635F-2645-4B5C-A1B3-EEF9E49B2DF4Q54550610-0E7C745E-8161-4263-94BF-23C2A61D72E5Q54961958-CFC02B57-D31C-48C6-B839-F79E1DB155EDQ55449361-C8BB4978-317C-4C53-BE62-2DFDB19DB836Q56514183-6255FA78-02ED-4EE5-851D-AE37D78AC54AQ60959907-8255F8EB-07BD-493D-8055-13A2D497AB7AQ61444266-3F61FD5B-1449-4176-908D-44581CEB6DD2Q63762389-48F8D150-0EE0-4F91-BE16-00E452611E03Q64922193-494304AD-D478-433E-891E-17730011FFA1Q67727841-D9FD8F70-431F-4473-A19D-507564FEB770Q67863827-2D3B1CE9-585B-411E-8370-9DEE5144FB3E
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Hervé BLOTTIERE
@ast
Hervé BLOTTIERE
@nl
Hervé Blottière
@de
Hervé Blottière
@en
Hervé Blottière
@es
Hervé Blottière
@fr
Hervé Blottière
@it
Hervé Blottière
@pt
type
label
Hervé BLOTTIERE
@ast
Hervé BLOTTIERE
@nl
Hervé Blottière
@de
Hervé Blottière
@en
Hervé Blottière
@es
Hervé Blottière
@fr
Hervé Blottière
@it
Hervé Blottière
@pt
prefLabel
Hervé BLOTTIERE
@ast
Hervé BLOTTIERE
@nl
Hervé Blottière
@de
Hervé Blottière
@en
Hervé Blottière
@es
Hervé Blottière
@fr
Hervé Blottière
@it
Hervé Blottière
@pt
P214
P1053
C-6120-2011
P106
P1153
7003533685
P214
P2798
P31
P496
0000-0002-8390-0607
P7859
viaf-203142055